Mitogen-activated protein kinases, inhibitory-kappaB kinase, and insulin signaling in human omental versus subcutaneous adipose tissue in obesity.
暂无分享,去创建一个
M. Stumvoll | I. Harman-boehm | M. Blüher | A. Rudich | N. Bashan | R. Potashnik | I. Liberty | Tanya Tarnovscki | E. Avinoach | S. Ovadia | K. Dorfman | Tali Maymon-Zilberstein
[1] M. Stumvoll,et al. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. , 2007, The Journal of clinical endocrinology and metabolism.
[2] A. Goldfine,et al. Inflammation and insulin resistance. , 2006, The Journal of clinical investigation.
[3] N. Abumrad,et al. Is all fat the same? The role of fat in the pathogenesis of the metabolic syndrome and type 2 diabetes mellitus. , 2006, Surgery.
[4] Avner Bar Hen,et al. Increased Infiltration of Macrophages in Omental Adipose Tissue Is Associated With Marked Hepatic Lesions in Morbid Human Obesity , 2006, Diabetes.
[5] H. Ichijo,et al. Impact of Mitochondrial Reactive Oxygen Species and Apoptosis Signal–Regulating Kinase 1 on Insulin Signaling , 2006, Diabetes.
[6] C. Kahn,et al. Evidence for a role of developmental genes in the origin of obesity and body fat distribution. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[7] R. Giorgino,et al. Insulin signaling in human visceral and subcutaneous adipose tissue in vivo. , 2006, Diabetes.
[8] J. Coselli,et al. Up-regulation of PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome Ten) Mediates p38 MAPK Stress Signal-induced Inhibition of Insulin Signaling , 2006, Journal of Biological Chemistry.
[9] J. Després,et al. Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease. , 2006, Journal of endocrinological investigation.
[10] H. Rubinfeld,et al. The ERK cascade , 2005, Molecular biotechnology.
[11] M. Fasshauer,et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. , 2005, Diabetes.
[12] C. Rondinone,et al. Pharmacological inhibition of p38 MAP kinase results in improved glucose uptake in insulin-resistant 3T3-L1 adipocytes. , 2005, Metabolism: clinical and experimental.
[13] H. Kaneto,et al. Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes , 2005, Journal of Molecular Medicine.
[14] A. Hevener,et al. IKK-β links inflammation to obesity-induced insulin resistance , 2005, Nature Medicine.
[15] Morihiro Matsuda,et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. , 2004, The Journal of clinical investigation.
[16] L. Glimcher,et al. Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes , 2004, Science.
[17] H. Ichijo,et al. The ASK1-MAP kinase cascades in mammalian stress response. , 2004, Journal of biochemistry.
[18] M. Quon,et al. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes. , 2004, Molecular endocrinology.
[19] J. Burén,et al. Glucocorticoids down-regulate glucose uptake capacity and insulin-signaling proteins in omental but not subcutaneous human adipocytes. , 2004, The Journal of clinical endocrinology and metabolism.
[20] Michael Karin,et al. The IKK NF-κB system: a treasure trove for drug development , 2004, Nature Reviews Drug Discovery.
[21] K. Wellen,et al. Obesity-induced inflammatory changes in adipose tissue. , 2003, The Journal of clinical investigation.
[22] S. Shoelson,et al. Inflammation and the IKKβ/IκB/NF-κB axis in obesity- and diet-induced insulin resistance , 2003, International Journal of Obesity.
[23] J. Tanti,et al. MAP kinases and mTOR mediate insulin-induced phosphorylation of Insulin Receptor Substrate-1 on serine residues 307, 612 and 632 , 2003, Diabetologia.
[24] Richard J Sciotti,et al. Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression. , 2003, Diabetes.
[25] I. Goldfine,et al. Are Oxidative StressActivated Signaling Pathways Mediators of Insulin Resistance and -Cell , 2003 .
[26] Joseph L Evans,et al. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? , 2003, Diabetes.
[27] Jianping Ye,et al. Serine Phosphorylation of Insulin Receptor Substrate 1 by Inhibitor κB Kinase Complex* 210 , 2002, The Journal of Biological Chemistry.
[28] Michael Karin,et al. A central role for JNK in obesity and insulin resistance , 2002, Nature.
[29] Joseph L Evans,et al. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. , 2002, Endocrine reviews.
[30] M. White,et al. Phosphorylation of Ser307 in Insulin Receptor Substrate-1 Blocks Interactions with the Insulin Receptor and Inhibits Insulin Action* , 2002, The Journal of Biological Chemistry.
[31] J. Hay,et al. Glucose uptake and insulin action in human adipose tissue—influence of BMI, anatomical depot and body fat distribution , 2002, International Journal of Obesity.
[32] G. Shulman,et al. Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. , 2001, The Journal of clinical investigation.
[33] J. Després,et al. Health consequences of visceral obesity , 2001, Annals of medicine.
[34] B. Wajchenberg. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. , 2000, Endocrine reviews.
[35] Michael Karin,et al. Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit Phosphorylation , 1999 .
[36] A. Rudich,et al. Oxidative Stress Disrupts Insulin-induced Cellular Redistribution of Insulin Receptor Substrate-1 and Phosphatidylinositol 3-Kinase in 3T3-L1 Adipocytes , 1999, The Journal of Biological Chemistry.
[37] Peter Arner,et al. Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway , 1998, Diabetologia.
[38] A. Greenberg,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by Glucocorticoid* , 1997 .
[39] J. Després,et al. Regional variation in adipose tissue insulin action and GLUT4 glucose transporter expression in severely obese premenopausal women , 1997, Diabetologia.
[40] Minoru Takagi,et al. Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling Pathways , 1997, Science.
[41] P. Arner,et al. Differences at the Receptor and Postreceptor Levels Between Human Omental and Subcutaneous Adipose Tissue in the Action of Insulin on Lipolysis , 1983, Diabetes.